Section Editors
- Michael Aschner, Vanderbilt University
- Phil Biggin, University of Oxford
- Lucio Guido Costa, University of Washington
- David H Farb, Boston University School of Medicine
- Giorgio Palu, University of Padova
Executive Editor
- Christopher Morrey, BioMed Central
Editorial Board | Editorial Team | Instructions for authors | FAQ
Articles
-
BMC Pharmacology and Toxicology 2013, 14:51Transformation for translational toxicology
The integration of exposure assessment, basic toxicology and models to investigate effective interventions that mitigate or reverse adverse effects of environmental exposures may represent an effective portfolio to improve health by minimizing exposure and producing specific therapeutics.
-
BMC Pharmacology and Toxicology 2013, 14:48Nebivolol-stimulated nitric oxide and peroxynitrite release
The ability of nebivolol to stimulate nitric oxide release appears to be independent of its selective beta1-adrenoceptor blockade properties and dependent on stimulation of beta3-adrenoceptors and ATP-mediated stimulation of P2Y-purinergic receptors in human endothelial cells.
-
BMC Pharmacology and Toxicology 2013, 14:42Breaking down the barrier of translational sciences
Section Editor David Farb provides his insights on recent developments in the field of pharmacology and discusses his future aspirations for BMC Pharmacology and Toxicology.
-
BMC Pharmacology and Toxicology 2013, 14:37A novel transcriptional sensor for GABA receptor activity
Polycomblike protein PHF1b stimulates GABRB1 promoter activity in primary cultured neurons and chronic GABA exposure regulates PHF1 binding to endogenous Gabrb1 indicating its role as a molecular transducer of GABA-mediated neurotransmission.
-
BMC Pharmacology and Toxicology 2013, 14:36Identification of a promising new CK2 inhibitor
Cell-free, in vitro and molecular docking studies indicate that the phytoestrogen coumestrol is a novel ATP competitive and cell permeable Casein kinase 2 (CK2) inhibitor with a submicromolar IC50.
-
BMC Pharmacology and Toxicology 2013, 14:31Modeling protein-protein interfaces involving an alpha helix
Computational analysis of proteins that interact with alpha-helical peptides suggests no sequence requirements for binding and highlights the presence of hydrophobic regions at the protein surface and non-uniform hydrophobicity across binding pockets.
- View more articles
Latest review
Review 
Role of astrocytes in manganese mediated neurotoxicity
Marta Sidoryk-Wegrzynowicz and Michael Aschner
BMC Pharmacology and Toxicology 2013, 14:23 (18 April 2013)Hot topic
Research article
BMC Pharmacology and Toxicology 2013, 14:43
News from the web
- 30 September 2013
- Scientists engineer bacteria using a hidden genetic code
- 26 September 2013
- Antibiotics withdrawn from the market three times more often than other drugs, according to new study
- 19 September 2013
- Beware of TV drug ads
Scope
BMC Pharmacology and Toxicology is an open access, peer-reviewed journal that considers articles on all aspects of chemically defined therapeutic and toxic agents. The journal welcomes submissions from all fields of experimental and clinical pharmacology including clinical trials.
It is journal policy to publish work deemed by peer reviewers to be a coherent and sound addition to scientific knowledge and to put less emphasis on interest levels, provided that the research constitutes a useful contribution to the field.
Section Editor's profile
David H Farb is Professor and Chair of the Department of Pharmacology and Experimental Therapeutics at Boston University School of Medicine. He is Principal Investigator and Director of the Laboratory of Molecular Neurobiology and Director of the university-wide NIGMS training program in Biomolecular Pharmacology. A renowned neuropharmacologist, his research integrates existing electrophysiological, behavioral, pharmacological, and molecular genetic technologies in a novel systems-level platform to establish a molecular dissection of spatial memory. Dr Farb is Section Editor for 'Basic pharmacology' and you can read more about the key issues in this field and his aspirations for the journal in his recent interview here.
"Pharmacology is a powerful interdisciplinary science providing an essential link between hypotheses developed from molecular, systems, and clinical models with the ultimate goal of improving human health. Our journal publishes timely research describing advances in a broad range of disciplines that combine novel approaches within a framework of rigorous scientific research."
Join the Editorial Board!
Are you interested in becoming an Editorial Board member for BMC Pharmacology and Toxicology and helping to maintain the editorial standards and ethos of this growing journal? To volunteer as an Associate Editor, please simply contact us at bmcpharmacoltoxicol@biomedcentral.com, enclosing a summary of your research interests and relevant expertise. We look forward to hearing from you.
BMC series blog
- 25 September 2013
- BMC and the Royal College of General Practitioners
- 19 September 2013
- Enhancing sexual health services through E-health technology
BMC Pharmacology
BMC Pharmacology and Toxicology assimilated the Editorial boards and history of BMC Pharmacology and BMC Clinical Pharmacology on fusion of the journals in 2012. The full archive of BMC Pharmacology is available from its own archive website, and the objectives and aspirations of the merged journal are explained in the editorial that accompanied the fusion. The full archive of BMC Clinical Pharmacology is available here.
Email updates
Receive periodic news and updates relating to BioMed Central straight to your inbox.
Indexed by
- CAS
- Embase
- Journal Citation Reports/Science Edition
- MEDLINE
- PubMed
- Science Citation Index Expanded
- Scopus
RSS
Comments
View more comments